Biographical Sketch
Dr. Bruce D. Lindsay is Section Head, Cardiac Electrophysiology and Pacing at the Cleveland Clinic. He served as President of the Heart Rhythm Society 2007-2008 and chaired the Heart Rhythm Society's Annual Scientific Program in Boston in 2006, which was attended by more than 13,000 international physicians, scientists, and allied health professionals. Dr. Lindsay recently completed a term on Board of Trustees for the American College of Cardiology, and formerly chaired the College's Board of Governors. He also serves on the ABIM test writing committee for Clinical Cardiac Electrophysiology.
Dr. Lindsay is a graduate of Jefferson Medical College and completed a residency in internal medicine at the University of Michigan. He served in the National Health Service Corps from 1980-83. He completed a cardiology fellowship at Washington University where he undertook additional training in the treatment of heart rhythm disorders. He joined the faculty at Washington University in 1985 and became Professor of Medicine and Director of Electrophysiology. He accepted the position of Section Head, Cardiac Electrophysiology and Pacing at the Cleveland Clinic in 2008.
His clinical research and publications have focused on identification of patients at increased risk for cardiac arrest, improved technology for implantable defibrillators, malfunctions of implantable cardiac devices, and advances in ablation of heart rhythm abnormalities. He is a contributing author for the Heart Rhythm Society?s recent state of the art consensus document for ablation of atrial fibrillation. Through his commitment to education he has served on the faculty at meetings throughout the United States, Europe, Japan, Taiwan, and China.
Specialty Interests
ablation of atrial and ventricular arrhythmias, Implantation of ICDs and Pacemakers
Innovations & Patents
Magnetic catheter navigation for ablation of atrial and ventricular arrhythmias
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 8/3/2008,
Dr. Lindsay has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
